Detalles de la búsqueda
1.
Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of treatment choice in stage III cutaneous melanoma in the US.
BMC Cancer
; 24(1): 389, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539148
2.
Safety differences across androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer.
Future Oncol
; 19(5): 385-395, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36794575
3.
Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study.
J Headache Pain
; 23(1): 47, 2022 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35410121
4.
Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine.
J Headache Pain
; 23(1): 56, 2022 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578182
5.
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.
J Urol
; 206(2): 298-307, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818140
6.
Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.
BMC Psychiatry
; 20(1): 365, 2020 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32652964
7.
Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis.
BMC Neurol
; 19(1): 174, 2019 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325958
8.
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Acta Derm Venereol
; 99(10): 851-857, 2019 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099402
9.
Systematic literature review of clinical trials of endocrine therapies for premenopausal women with metastatic HR+ HER2- breast cancer.
Breast J
; 25(5): 880-888, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31290203
10.
Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia.
BMC Psychiatry
; 18(1): 306, 2018 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30249218
11.
Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison.
Eur Child Adolesc Psychiatry
; 26(8): 875-897, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28258319
12.
Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment.
Value Health
; 18(2): 198-205, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773555
13.
Clinical outcomes before and after prucalopride treatment: an observational study in patients with chronic idiopathic constipation in the USA.
Clin Transl Gastroenterol
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357940
14.
Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta-analyses in dialysis and non-dialysis dependent populations.
Clin Kidney J
; 17(1): sfad298, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250252
15.
Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States.
J Clin Psychiatry
; 84(3)2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37022752
16.
Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States.
J Patient Rep Outcomes
; 7(1): 122, 2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015301
17.
Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia.
Ment Health Clin
; 13(5): 207-216, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131057
18.
An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia.
Clin Psychopharmacol Neurosci
; 20(1): 154-166, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078958
19.
Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.
Adv Ther
; 39(4): 1784-1793, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195860
20.
Defining utility values for patients with tardive dyskinesia.
Curr Med Res Opin
; 38(3): 401-407, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35045768